Joseph Larosa - Mar 23, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/** Joseph LaRosa
Stock symbol
REGN
Transactions as of
Mar 23, 2023
Transactions value $
-$2,700,020
Form type
4
Date filed
3/27/2023, 04:39 PM
Previous filing
Mar 14, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $2.7M +10K +41.3% $270.43 34.2K Mar 23, 2023 Direct
transaction REGN Common Stock Tax liability -$5.4M -6.74K -19.71% $801.59 27.5K Mar 23, 2023 Direct
holding REGN Common Stock 5.32K Mar 23, 2023 2022 GRAT
holding REGN Common Stock 335 Mar 23, 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00* 0 Mar 23, 2023 Common Stock 10K $270.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.